Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Link Pharma Chem Limited engages in the manufacturing and selling of drugs intermediates for pharmaceutical, agriculture, cosmetics, and veterinary Industries in India. It also engages in custom synthesis/contract manufacturing for multistage synthesis for small, medium, and large companies; development of multistep pathways for organic synthesis; and refinement and optimization of existing synthetic methods. In addition, the company offers fragrance intermediates. Link Pharma Chem Limited was incorporated in 1984 and is based in Vadodara, India.
Key Metrics
as of Sep 2026
Market Cap 12 Cr
P/E β
Div Yield 0.00 %
Book Value βΉ28.80
52w High βΉ41.90
52w Low βΉ21.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
8.77
6.59
6.73
6.29
7.81
6.45
5.34
4.80
8.85
8.03
7.94
6.05
7.88
Expenses
8.32
6.83
6.04
5.95
7.17
6.68
5.23
5.10
8.30
7.12
7.66
6.93
8.84
Operating Profit
0.45
-0.24
0.69
0.34
0.64
-0.23
0.11
-0.30
0.55
0.91
0.28
-0.88
-0.96
OPM %
5.13
-3.64
10.25
5.41
8.19
-3.57
2.06
-6.25
6.21
11.33
3.53
-14.55
-12.18
Other Income
0.35
0.15
-0.20
0.05
0.21
0.12
-0.56
0.36
0.27
-0.01
0.37
-0.03
0.31
Depreciation
0.27
0.25
0.25
0.25
0.24
0.24
0.24
0.24
0.24
0.25
0.27
0.26
0.26
Interest
0.14
0.15
0.14
0.13
0.10
0.14
0.21
0.21
0.22
0.19
0.23
0.22
0.23
Profit before tax
0.39
-0.49
0.10
0.01
0.51
-0.49
-0.90
-0.39
0.36
0.46
0.15
-1.39
-1.14
Tax %
17.95
-16.33
40.00
0.00
21.57
-26.53
-24.44
-20.51
16.67
45.65
-46.67
-26.62
-28.07
Net Profit
0.32
-0.41
0.07
0.02
0.40
-0.35
-0.67
-0.31
0.30
0.26
0.22
-1.02
-0.82
EPS in Rs
0.72
-0.92
0.16
0.05
0.90
-0.79
-1.51
-0.70
0.68
0.59
0.50
-2.30
-1.85
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
27.43 25.43 29.90 38.76 53.56 34.81 25.47 24.50 23.53 16.10 12.35 17.58
Expenses
25.98 25.30 30.55 36.04 50.02 31.67 22.05 22.48 20.75 13.56 12.16 18.36
Operating Profit
1.45 0.13 -0.65 2.72 3.54 3.14 3.42 2.02 2.78 2.54 0.19 -0.78
OPM %
5.29 0.51 -2.17 7.02 6.61 9.02 13.43 8.24 11.81 15.78 1.54 -4.44
Other Income
0.20 0.19 0.64 -0.15 0.46 -0.15 -0.69 0.19 0.07 -0.43 2.39 0.21
Interest
0.53 0.78 0.87 0.76 0.45 0.44 0.36 0.39 0.62 0.80 0.91 1.44
Depreciation
0.98 0.94 1.03 0.92 0.93 0.87 0.93 0.89 0.86 0.83 0.93 1.13
Profit before tax
0.14 -1.40 -1.91 0.89 2.62 1.68 1.44 0.93 1.37 0.48 0.74 -3.14
Tax %
42.86 -26.43 -28.80 26.97 28.24 35.12 34.03 29.03 17.52 54.17 20.27 -29.94
Net Profit
0.08 -1.03 -1.36 0.65 1.88 1.08 0.95 0.66 1.13 0.23 0.59 -2.20
EPS in Rs
0.18 -2.32 -3.06 1.46 4.23 2.43 2.14 1.49 2.54 0.52 1.33 -4.95
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
4.44 4.44 4.44 4.44 4.44 4.44 4.44 4.44 4.44 4.44 4.44 4.44
Reserves
8.35 8.22 9.27 10.60 10.03 8.12 6.99 5.94 5.35 4.16 4.52 3.93
Borrowings
7.31 5.78 9.22 8.76 6.39 3.66 3.56 2.64 2.71 4.73 5.41 10.80
Other Liabilities
4.87 4.86 3.02 8.66 8.10 9.82 3.98 4.99 4.69 3.81 3.46 7.35
Total Liabilities
24.97 23.30 25.95 32.46 28.96 26.04 18.97 18.01 17.19 17.14 17.83 26.52
Fixed Assets
10.38 9.28 9.94 9.00 8.79 8.71 8.81 9.14 9.76 9.57 10.13 17.51
CWIP
0.00 0.00 0.00 0.00 0.21 0.00 0.00 0.43 0.01 0.00 0.00 0.00
Investments
2.47 2.06 2.93 3.64 4.52 0.03 0.03 0.03 0.03 0.03 0.02 0.02
Other Assets
12.12 11.96 13.08 19.82 15.44 17.30 10.13 8.41 7.39 7.54 7.68 8.99
Total Assets
24.97 23.30 25.95 32.46 28.96 26.04 18.97 18.01 17.19 17.14 17.83 26.52
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
2.15 2.69 -0.03 -1.71 -1.26 4.84 2.95 1.36 3.79 2.23 -3.91 5.13
Cash from Investing Activity
-2.66 1.53 0.41 -0.08 -4.97 -2.16 -1.66 -0.96 -1.15 -0.73 8.72 -3.27
Cash from Financing Activity
0.99 -4.21 -0.41 1.61 2.27 -0.33 0.55 -0.46 -2.63 -1.48 -5.75 -0.87
Net Cash Flow
0.48 0.00 -0.03 -0.17 -3.95 2.35 1.85 -0.05 0.00 0.02 -0.94 0.99
Free Cash Flow
0.05 2.43 -0.86 -2.60 -2.01 3.13 1.27 0.49 2.63 1.37 4.80 1.84
CFO/OP %
150.00 2,046.00 -52.00 -48.00 -17.00 169.00 83.00 77.00 147.00 92.00 -2,005.00 -658.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
70.26 72.05 62.87 34.18 36.60 58.19 71.51 45.29 49.33 49.42 68.86 63.74
Inventory Days
170.29 166.94 135.89 209.23 47.68 51.35 60.04 92.54 96.96 285.97 277.34 125.34
Days Payable
110.59 101.21 38.51 112.90 45.37 140.70 110.86 108.98 124.25 202.93 81.61 94.59
Cash Conversion Cycle
129.96 137.78 160.24 130.51 38.90 -31.16 20.68 28.85 22.05 132.47 264.59 94.49
Working Capital Days
-7.05 15.07 5.13 26.74 14.17 10.49 51.45 31.43 31.64 0.23 -6.80 -46.92
ROCE %
3.48 -3.00 -4.79 6.72 13.16 14.61 18.71 10.34 15.41 13.00 -3.64 -8.74
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
52.40
52.40
51.49
51.49
51.49
51.49
51.49
51.49
51.49
51.49
51.49
51.49
DIIs
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Public
47.58
47.59
48.49
48.49
48.50
48.49
48.50
48.49
48.49
48.50
48.50
48.49
No. of Shareholders
6,005
6,020
6,063
6,090
6,112
6,160
6,181
6,151
6,083
6,200
6,132
6,212
Back to all stocks